Table 2 Comparison of post-catherization diagnosis and biomarkers between patients who had survived and patients who had died by the 1-year follow-up
From: Indoleamine 2,3 dioxygenase (IDO) level as a marker for significant coronary artery disease
Parameters | Survived (n = 293) | Died (n = 12) | p-value |
|---|---|---|---|
All patients (N = 305) | |||
Baseline hs-TnT | 12.96 (3.09, 294.20) | 15.89 (10.41, 61.03) | 0.154 |
Baseline Kynurenine | 5.07 (0.00, 11,731.00) | 0.79 (0.00, 32.84) | 0.082 |
Baseline IDO activity | 0.15 (0.00, 4.58) | 0.02 (0.00, 0.79) | 0.081 |
Insignificant CAD/SVD patients (n = 159) | Survived (n = 155) | Died (n = 4) | |
|---|---|---|---|
Baseline hs-TnT | 11.53 (3.09, 141.50) | 13.24 (12.89, 16.92) | 0.492 |
Baseline Kynurenine | 4.68 (0.00, 7892.33) | 0.38 (0.00, 0.82) | 0.037 |
Baseline IDO activity | 0.13 (0.00, 4.13) | 0.01 (0.00, 0.02) | 0.040 |
DVD/TVD patients (n = 146) | Survived (n = 138) | Died (n = 8) | |
|---|---|---|---|
Baseline hs-TnT | 15.93 (4.53, 294.20) | 17.63 (10.41, 61.03) | 0.355 |
Baseline Kynurenine | 5.58 (0.00, 11,731.00) | 2.28 (0.39, 32.84) | 0.380 |
Baseline IDO activity | 0.16 (0.00, 4.58) | 0.06 (0.01, 0.79) | 0.380 |